Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2356224
下载链接
链接失效反馈官方服务：
资源简介：
This clinical trial is evaluating a drug called SNX281 given by itself and in combination with pembrolizumab in participants with advanced solid tumors and lymphoma. The main goals of this study are to:
* Find the recommended dose of SNX281 that can be given to participants safely alone and in combination with pembrolizumab.
* Learn more about the side effects and safety profile of SNX281 alone and in combination with pembrolizumab
* Learn more about pharmacological characteristics of SNX281 alone and in combination with pembrolizumab
* Learn more about effectiveness of SNX281 alone and in combination with pembrolizumab
创建时间：
2020-11-15
